Mark Costa, MD, MPH, and Elizabeth Flanagan, PhD, from the Yale Program for Recovery and Community Health, have received a NIMH R61/R33 award to study the Community-Based Intensive Treatment Program (CBIT).
Their work will be done in collaboration with Larry Nulton, PhD, from the Nulton Diagnostics and Treatment Center in Pennsylvania.
The research will implement and evaluate the CBIT, a high-intensity, community-centered outpatient model for rural adults with serious mental illness after they are discharged from psychiatric care.
CBIT combines evidence-based approaches, including assertive community treatment, critical time intervention, and integrated care planning, through partnerships between local behavioral health providers and community supports.
In the R61 phase, the researchers will establish a community-based participatory research infrastructure, prepare three to five Pennsylvania counties to implement CBIT, and pilot study procedures with 10 participants to assess feasibility, acceptability, safety, and tolerability.
Meeting prespecified benchmarks will determine whether the project advances to the R33 phase, where the researchers would conduct a fully powered Hybrid Type 1 randomized clinical trial of CBIT in rural Pennsylvania.
They would also evaluate implementation outcomes and use the CFIR framework and a collaborative of providers, service users, and county administrators to identify factors that support sustainable adoption of CBIT.